课题基金 / 基金详情

DONOR CD8 EFFECTOR FUNCTION IN MARROW TRANSPLANTATION

DONOR CD8 EFFECTOR FUNCTION IN MARROW TRANSPLANTATION
供体 CD8 效应器在骨髓移植中的功能
批准号:
2655283
负责人:
David Ian Kingston Martin
金额:
$22.44万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-02-01 至 2001-01-31

项目摘要

项目成果

David Ian Kingston Martin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): The long term goal of this project is to identify a population of donor T cells that can be used to prevent graft rejection without significant graft versus host disease after allogeneic bone marrow transplantation. In order to assess the feasibility of using CD8 cells to assure engraftment without causing GVHD, the phenotype and function of donor CD8+ T cells must be established. The investigator will test: (1) whether the desired cell must be cytotoxic, (2) whether alloantigens expressed only on lymphohematopoietic cells are more effective targets than broadly expressed alloantigens, (3) whether T cells with low affinity TCR are better than T cells with high affinity TCR, and (4) whether donor T cells must migrate and home to lymph nodes in order to prevent rejection. In addition, the role of alloimmunization of the recipient will be tested. Identification of a CD8 population that can prevent rejection without causing GVHD in mice will lead to the testing of similar approaches in humans. These results will be of importance not only for allogeneic bone marrow transplantation but also for the design of novel adoptive immunotherapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A high-throughput screen for candidate agents that may reverse gamma-globin silen
A high-throughput screen for candidate agents that may reverse gamma-globin silen
An Assay to Identify and Classify Epimutagens
An Assay to Identify and Classify Epimutagens
海外基金